Febugood 80 Tablet contains Febuxostat 80mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body, thereby preventing the formation of urate crystals that cause joint inflammation and pain associated with gout. This tablet is typically prescribed for adults who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. Febugood 80 is taken orally, usually once daily, and should be used under medical supervision to monitor uric acid levels and kidney function. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities, so regular follow-up is essential. Patients with a history of cardiovascular disease should use Febugood cautiously, as some studies suggest a potential increased risk of heart-related events. It is important to maintain adequate hydration while on this medication to help prevent kidney stones. Febugood 80 should not be used during pregnancy or breastfeeding unless clearly needed, and patients should inform their healthcare provider about all other medications they are taking to avoid interactions. Overall, Febugood 80 Tablet is an effective option for long-term management of gout and hyperuricemia when used as directed.